Only a limited number of cases have demonstrated concurrent JAK2 and MPL mutations, which have been associated with myelodysplastic/MPNs, polycythemia vera, and essential thrombocythemia [6–8, 10]. Here, MPL is linked to acquired polycythemia vera.